Evidence map›Paper›PMID 27081166›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2016

GM-CSF Enhances Macrophage Glycolytic Activity In Vitro and Improves Detection of Inflammation In Vivo.

Parmanand Singh, Silvia González-Ramos, Marina Mojena, César Eduardo Rosales-Mendoza, Hamed Emami, Jeffrey Swanson, Alex Morss, Zahi A Fayad, James H F Rudd, Jeffrey Gelfand and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Use ofJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. HIF1Oxidative medicine and cellular longevity · 2019
    Article
  16. Review
  17. Review
  18. Molecular imaging
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 4 countries.

Parmanand SinghCardiology Division, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York.
Silvia González-RamosInstituto de Investigaciones Biomédicas "Alberto Sols," CSIC-UAM, Madrid, Spain.
Marina MojenaInstituto de Investigaciones Biomédicas "Alberto Sols," CSIC-UAM, Madrid, Spain.
César Eduardo Rosales-MendozaInstituto de Investigaciones Biomédicas "Alberto Sols," CSIC-UAM, Madrid, Spain Departamento de Bioquímica y Medicina Molecular, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México.
Hamed EmamiCardiac MR PET CT Program, Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Jeffrey SwansonCardiac MR PET CT Program, Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Alex MorssCardiac MR PET CT Program, Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Zahi A FayadTranslational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
James H F RuddDivision of Cardiovascular Medicine, University of Cambridge, Cambridge, United Kingdom.
Jeffrey GelfandDivision of Infectious Diseases, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; and.
Marta Paz-GarcíaInstituto de Investigaciones Biomédicas "Alberto Sols," CSIC-UAM, Madrid, Spain.
Paloma Martín-SanzInstituto de Investigaciones Biomédicas "Alberto Sols," CSIC-UAM, Madrid, Spain Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Instituto de Salud Carlos III, Madrid, Spain.
Lisardo BoscáInstituto de Investigaciones Biomédicas "Alberto Sols," CSIC-UAM, Madrid, Spain Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Instituto de Salud Carlos III, Madrid, Spain.
Ahmed TawakolCardiac MR PET CT Program, Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts lbosca@iib.uam.es.
Harvard University · USUniversidad Autónoma de Madrid · ESInstituto de Investigaciones Biomédicas Sols-Morreale · ESMassachusetts General Hospital · USCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESIcahn School of Medicine at Mount Sinai · USNew York Hospital Queens · USUniversity of Cambridge · GB

Funding

MR/PET Imaging of coronary atherosclerosisR01HL071021 · NHLBI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI FAYAD, ZAHI A. · 2002 to 2019
$7.8M
Theranostic HDL nanoparticles for inflammatory macrophages in atherosclerosisR01EB009638 · NIBIB · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FAYAD, ZAHI A. · 2009 to 2016
$4.6M
Nanoparticles for Molecular MRI of AtherosclerosisR01HL078667 · NHLBI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI FAYAD, ZAHI A. · 2004 to 2008
$2.5M
Effect of Low Dose Methotrexate on Arterial Inflammation in HIVR01HL122177 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI TAWAKOL, AHMED A · 2014 to 2017
$1.2M
British Heart Foundation FS/12/29/29463British Heart Foundation PG/09/083/27667NHLBI NIH HHS HHSN268201000045CNHLBI NIH HHS R01 HL071021NHLBI NIH HHS R01 HL078667NHLBI NIH HHS R01 HL122177NIBIB NIH HHS R01 EB009638
6 · The paper itself

Abstract

unlabelled(18)F-FDG accumulates in glycolytically active tissues and is known to concentrate in tissues that are rich in activated macrophages. In this study, we tested the hypotheses that human granulocyte-macrophage colony-stimulating factor (GM-CSF), a clinically used cytokine, increases macrophage glycolysis and deoxyglucose uptake in vitro and acutely enhances (18)F-FDG uptake within inflamed tissues such as atherosclerotic plaques in vivo.

methodsIn vitro experiments were conducted on human macrophages whereby inflammatory activation and uptake of radiolabeled 2-deoxyglucose was assessed before and after GM-CSF exposure. In vivo studies were performed on mice and New Zealand White rabbits to assess the effect of GM-CSF on (18)F-FDG uptake in normal versus inflamed arteries, using PET.

resultsIncubation of human macrophages with GM-CSF resulted in increased glycolysis and increased 2-deoxyglucose uptake (P < 0.05). This effect was attenuated by neutralizing antibodies against tumor necrosis factor-α or after silencing or inhibition of 6-phosphofructo-2-kinase. In vivo, in mice and in rabbits, intravenous GM-CSF administration resulted in a 70% and 73% increase (P < 0.01 for both), respectively, in arterial (18)F-FDG uptake in atherosclerotic animals but not in nonatherosclerotic controls. Histopathologic analysis demonstrated a significant correlation between in vivo (18)F-FDG uptake and macrophage staining (R = 0.75, P < 0.01).

conclusionGM-CSF substantially augments glycolytic flux in vitro (via a mechanism dependent on ubiquitous type 6-phosphofructo-2-kinase and tumor necrosis factor-α) and increases (18)F-FDG uptake within inflamed atheroma in vivo. These findings demonstrate that GM-CSF can be used to enhance detection of inflammation. Further studies should explore the role of GM-CSF stimulation to enhance the detection of inflammatory foci in other disease states.

Indexed as

AnimalsArteritisCells, CulturedFluorodeoxyglucose F18GlycolysisGranulocyte-Macrophage Colony-Stimulating FactorHumansImage EnhancementMacrophagesMaleMicePositron-Emission TomographyRabbitsRadiopharmaceuticalsReproducibility of ResultsSensitivity and SpecificityFluorodeoxyglucose F18Granulocyte-Macrophage Colony-Stimulating FactorRadiopharmaceuticals18F-FDG-PETglycolysisGM-CSFinflammationmacrophage

Identifiers

PMID27081166
PMCPMC5093920
OpenAlexW2342101280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.